Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MEDGENICS, INC. | 140,000 | reported | 18 Feb 2015 | tx 3+950,314 |
| IMPEL NEUROPHARMA INC | 70,000 | reported | 14 Feb 2023 | tx 7+241,142−14,198 |
| Cartesian Therapeutics, Inc. | 50,000 | reported | 15 Jun 2018 | tx 2+270,000 |
| Traws Pharma, Inc. | 33,435 | reported | 08 Mar 2026 | tx 5+82,106 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Mar 2026 | GRANT_AWARD | Traws Pharma, Inc. | 33,435 | 0.00 USD | deriv |
| 12 Dec 2025 | GRANT_AWARD | Traws Pharma, Inc. | 4,058 | 0.00 USD | |
| 12 Dec 2025 | GRANT_AWARD | Traws Pharma, Inc. | 16,234 | 0.00 USD | deriv |
| 21 Nov 2025 | GRANT_AWARD | Traws Pharma, Inc. | 12,770 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Traws Pharma, Inc. | 15,609 | 0.00 USD | deriv |
| 14 Feb 2023 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 70,000 | 0.00 USD | deriv |
| 31 Dec 2022 | EXERCISE | IMPEL NEUROPHARMA INC | 10,571 | 0.00 USD | |
| 31 Dec 2022 | TAX_WITHHOLDING | IMPEL NEUROPHARMA INC | 3,627 | 3.75 USD | |
| 31 Dec 2022 | EXERCISE | IMPEL NEUROPHARMA INC | 10,571 | 0.00 USD | deriv |
| 26 Jan 2022 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 100,000 | 0.00 USD | deriv |
| 19 Oct 2021 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 10,571 | 0.00 USD | deriv |
| 20 Jul 2021 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 50,000 | 0.00 USD | deriv |
| 15 Jun 2018 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 17 Nov 2017 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 220,000 | 0.00 USD | deriv |
| 18 Feb 2015 | GRANT_AWARD | MEDGENICS, INC. | 140,000 | 0.00 USD | deriv |
| 16 Apr 2014 | GRANT_AWARD | MEDGENICS, INC. | 10,314 | 5.37 USD | deriv |
| 13 Sept 2013 | GRANT_AWARD | MEDGENICS, INC. | 800,000 | 0.00 USD | deriv |